GE offers update on business impact of COVID-19
The COVID-19 outbreak is having a major impact on GE's aviation business, but...Read more on AuntMinnie.comRelated Reading: GE Healthcare reports marginal growth in 2019 Expansion of AI tools highlights GE at RSNA FDA clears GE's Clariscan macrocyclic GBCA GE Healthcare revenues rise in Q3 GE, Premier partner on one-stop breast cancer center
ConclusionsDespite the introduction of strict COVID-19 control measures, there was a high level of cancer outpatient satisfaction. The satisfaction levels may influence compliance, continuity of treatments, and patient –doctor communication, impacting the quality of clinical care in the next phases of the pandemic.
As solutions like remote care are becoming the norm, 3D-printing disrupts the normal supply chain and even the number of life science studies on tools like artificial intelligence (A.I.) skyrocket, it’s become clear that we are not anticipating the digital health era; we are in the digital health era due to the COVID-19 pandemic. First and foremost, it’s an era defined by a cultural transformation that will upend the traditional structure of healthcare. Clinical-grade sensors are available outside of the ivory towers of medicine; patients demand such tools so that they can become more proactive in mana...
Background: It is widely accepted that multidisciplinary team meetings (MTM) ensure higher quality of care and improved survival in breast cancer (BC) patients. During the COVID-19 outbreak in Northern Italy, in the large territory of ULSS6 “Euganea” (province of Padova, nearly one million people and 3 local hospitals: Cittadella – CTD, Camposampiero – CSP, Schiavonia -SCH) since the end of February 2020, SCH were turned into “COVID-19 hospital” and BC cancer patients were then transferred to CTD in order to underwent surge ry.
Background: The recent COVID-19 pandemic has caused profound changes on the health-care systems as well as deleterious repercussions on the care of patients with cancer. In this comparative study, we sought to evaluate the effects the COVID-19 pandemic on the surgical management of breast cancer in a Breast Unit belonging to an Italian region with a low incidence of COVID-19 infection.
This article summarizes the effect of the global pandemic – and efforts to curtail its spread – on both breast cancer care and on breast imaging pract ices including effects on patients, clinical workflow, education and research.
No abstract available
CONCLUSION: In the "COVID-19 era", fast track awake breast surgery provides a reduction of ORT, LOS and potentially surgical treatment for a wider number of oncological patients. PMID: 32734327 [PubMed - as supplied by publisher]
ConclusionsThis commentary focused on breast cancer patients and provided suggestions to avoid the spread of COVID-19. Some of these suggestions are also suitable for cancer patients in other lesions. We hope our suggestions are useful to oncologists in other countries and help them to overcome this challenge.
The coronavirus disease 2019 (COVID-19) outbreak caused by the novel coronavirus (SARS-CoV-2), which originated in Wuhan (China), has now spread across the globe affecting millions of people worldwide.1 COVID-19 is a hypercoagulable state and may lead to both venous and arterial thromboembolic events.2 This state is more common in cancer patients owing to an immunosuppressed state.3 Therefore, a thorough evaluation of the vascular system is warranted in these patients.